News From January 2022

Published on 02/01/2022

5 min read

Newsletter updates for January 2022
News from SOPHiA GENETICS – January 2022

alt_text

Newsletter – January 2022

Presentation at J.P. Morgan 2022

Earlier this month we had the chance to share our accomplishments and our vision with the world as we presented at the 40th Annual J.P. Morgan Health Care Conference. If you missed our webcast, just click the link below for the recording with our CEO Jurgi Camblong and CFO Ross Muken. 

Strong Traction for DEEP-Lung-IV

Also announced at J.P. Morgan, our multimodal clinical study is off to a strong start with 12 sites across 5 countries already signing up. 

Mitochondrial DNA Analysis

Watch our video to discover how SOPHiA GENETICS is simplifying mitochondrial DNA analysis with SOPHiA DDM™️

2022 Best Places to Work Boston

We’ve been named one of the top 100 places to work in the Boston area by Built In. If you’d like to join our team, take a look at our careers page.

New Executive Team Additions

Please join us in welcoming three recent additions to our Executive Team who bring many years of experience and strategy to SOPHiA GENETICS.

Upcoming events


 

SCOPE 2022 – Orlando
February 7, 2022 – February 10, 2022
In-person, Virtual


ACMG – Nashville
March 23, 2022 – March 26, 2022
In-person, Virtual


AACR – New Orleans
April 8, 2022 – April 12, 2022
In-person, Virtual

In The News


 

GenomeWeb

Peter Casasanto, Abhi Verma
 

Massive Science 

The Great Pandemic Stress Test

Yahoo! Finance

SOPHiA GENETICS Appoints Ken Freedman as Chief Revenue Officer

Pharma’s Almanac

Q: For what therapeutic area do you think we will see the greatest progress in the coming years?

Pharma’s Almanac

Q: What do you see as the key innovations or technologies that will make personalized/precision medicine a reality?

arrow arrow arrow arrow arrow

DISCLAIMER

The information included in this document has been prepared for and is intended for viewing by a global audience. This document contains information about products and services which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indication for use. Please consult local sales representative.

 

alt_text

pink dots icon

Related Posts

pink dots icon

Want to know more?
Get in touch with us.

Our client services team is on hand to help.